Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Inventory (2022 - 2025)

Neuraxis' Change in Inventory history spans 4 years, with the latest figure at -$9578.0 for Q3 2025.

  • For Q3 2025, Change in Inventory rose 47.44% year-over-year to -$9578.0; the TTM value through Sep 2025 reached $119499.0, up 1289.99%, while the annual FY2024 figure was $32500.0, 220.76% up from the prior year.
  • Change in Inventory for Q3 2025 was -$9578.0 at Neuraxis, down from $106752.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $106752.0 in Q2 2025 and bottomed at -$32813.0 in Q2 2023.
  • The 4-year median for Change in Inventory is -$6907.0 (2025), against an average of $7014.7.
  • The largest YoY upside for Change in Inventory was 374.12% in 2025 against a maximum downside of 573.2% in 2025.
  • A 4-year view of Change in Inventory shows it stood at -$9188.0 in 2022, then plummeted by 44.86% to -$13310.0 in 2023, then surged by 319.62% to $29232.0 in 2024, then plummeted by 132.77% to -$9578.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Change in Inventory are -$9578.0 (Q3 2025), $106752.0 (Q2 2025), and -$6907.0 (Q1 2025).